Health News Releases

October 05, 2022 17:15

Last-mile veterinary delivery social start-up Cowtribe first investment of Boehringer Ingelheim Social Engagements

Boehringer Ingelheim announced today that Cowtribe is the first recipient of investment and non-financial support from the Boehringer Ingelheim Social Engagement (BI SE) initiative, a program which ai

October 05, 2022 14:30

Frazier Life Sciences Adds Experienced Biopharmaceutical Executive to Team

Frazier Life Sciences announced the addition of Jan Møller Mikkelsen as a Senior Advisor. He has over 30 years of experience as a biopharmaceutical executive. Mr. Mikkelsen founded Ascendis Pharma

October 04, 2022 16:42

DentalMonitoring Expands into Japan

New office in Tokyo; bringing smarter dentistry solutions to Japan. DentalMonitoring, the leading global provider of smart dentistry solutions, is setting foot in Japan to serve the Asian market wi

October 04, 2022 15:30

Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation

Treatment of cancer using one’s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, rad

October 04, 2022 11:40

The Estée Lauder Companies Launches 2022 Breast Cancer Campaign to Honor 30th Anniversary and Positively Impact the Global Breast Cancer Community

In the 30 years since Evelyn H. Lauder launched The Estée Lauder Companies’ Breast Cancer Campaign (The Campaign) and co-created the Pink Ribbon in 1992, The Campaign’s mission to help create a breast

September 30, 2022 10:30

Burjeel Holdings Lights Up Burj Khalifa With New Campaign Featuring Shah Rukh Khan

A month ahead of his birthday, Indian actor Shah Rukh Khan lit up the world’s tallest building, The Burj Khalifa, on Wednesday evening, in a brand campaign for the UAE-based conglomerate Burjeel Holdi

September 30, 2022 09:10

Monrol Will Establish a Legal Entity and Manufacturing Facility in Germany

Following an ongoing assessment of its entire operation, Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has decided to establish a legal entity and manufacturing facility in Germany. The new facil

September 29, 2022 13:43

Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company

Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New

September 28, 2022 17:10

Biocytogen to Present at BioJapan2022, Introducing Innovative R&D Platforms, Bispecific ADC Programs and Pipeline Progress

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will host a seminar at the BioJapan2022 Conference on Friday, October 14. The seminar, consisting of 3 modules, will introduc

September 28, 2022 16:34

Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the release of the THUNDERBEAT(TM) Open Fine Jaw Type

September 27, 2022 17:40

New Survey from Philip Morris International Reveals Strong Societal Support for Disruptive Innovations to Drive Public Health Progress

A new international survey released today by Philip Morris International Inc. (PMI) (NYSE: PM) reveals that despite broad public support for disruptive innovation to address global challenges, issues

September 27, 2022 17:15

Covetrus Names Michelle Bonfilio as Chief People Officer

Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and

September 23, 2022 13:30

Ferring Receives Positive Vote from U.S. FDA Advisory Committee for RBX2660

Ferring Pharmaceuticals today announced that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) issued a positive vote for RBX2660,

September 22, 2022 15:00

Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor

Merck, a leading science and technology company, today announced a collaboration agreement with licensing option with Nerviano Medical Sciences S.r.l. (NMS) for the next-generation highly selective an

September 22, 2022 14:35

Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck

Nerviano Medical Sciences S.r.l. (NMS), a member of the NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, announced today the signing

September 20, 2022 17:20

Galderma Debuts The Sensitive Skincare Faculty, a Global Expert Group to Improve Understanding and Management of Sensitive Skin

Reinforcing its commitment to advancing dermatology for every skin story, Galderma announced today the formation of a global Sensitive Skincare Faculty, which will focus its efforts on helping people

September 20, 2022 10:30

Takeda Signs Virtual Power Purchase Agreement with Enel North America to Advance Renewable Energy Production in the United States

Takeda (TSE:4502/NYSE:TAK) and Enel North America today announced the signing of a long-term virtual power purchase agreement (VPPA) for the electricity delivered to the power grid from a 79 megawatt

September 19, 2022 14:10

LEO Pharma Receives Positive CHMP Opinion of Adtralza® (tralokinumab) for the Treatment of Adolescents With Moderate-to-Severe Atopic Dermatitis

LEO Pharma A/S, a global leader in medical dermatology, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opi

September 19, 2022 10:30

Takeda Receives Positive CHMP Opinion for Maribavir for the Treatment of Adults with Post-transplant Cytomegalovirus (CMV) Refractory (With or Without Resistance) to Prior Therapies

Takeda (TSE:4502/NYSE:TAK) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of maribavir for the treatment of cy

September 19, 2022 09:40

Olympus Launches VISERA ELITE III Surgical Visualization Platform

Olympus Corporation (“Olympus” - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) today announced the launch of VISERA ELITE III, its newest surgical visualization platfo

September 16, 2022 15:40

Hyperice Brings the Heat With Introduction of All-New Venom Go and Venom 2

Hyperice, a global high-performance wellness brand, today announced two new products within their heat therapy category, Venom Go and Venom 2, alongside HyperHeat™ technology for the fastest, most con

September 16, 2022 11:55

DentalMonitoring Launches DM Insights

DM Insights joins the DM Intelligent Platform, DentalMonitoring’s full suite of solutions designed to improve the quality of care and the patient experience while growing practices at the same time. M

September 16, 2022 11:20

UAE’s Burjeel Medical City Successfully Carries Out Its First Kidney Transplant

Providing an option for local and international patients to undergo kidney transplantation in private hospitals in the UAE’s Abu Dhabi, Burjeel Medical City (BMC) has started performing kidney transpl

September 15, 2022 15:30

Biocytogen Announces Collaboration with FineImmune to Develop TCR-Mimic Antibody-based Cell Therapy

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) announced a strategic collaboration with Guangzhou FineImmune Biotechnology Co., LTD. (“FineImmune”) to co-develop cell-based

September 15, 2022 14:00

Prolific Machines Raises $42M From Top Planetary Health Investors to Build the Assembly Line for Biology

Prolific Machines, a next generation biotechnology company, is emerging from stealth today by announcing their massively oversubscribed Seed and Series A financings, led by the best VCs in the space.

News by Region

News by Industry